MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Thoratec Company Profile (NASDAQ:THOR)

Consensus Ratings for Thoratec (NASDAQ:THOR) (?)
Ratings Breakdown: 6 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $50.75 (20.08% downside)

Analysts' Ratings History for Thoratec (NASDAQ:THOR)
Show:
DateFirmActionRatingPrice TargetActions
12/3/2015JPMorgan Chase & Co.Reiterated RatingNeutral$36.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Leerink SwannBoost Price TargetOutperform$32.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Canaccord GenuityBoost Price TargetBuy$39.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Goldman SachsUpgradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$56.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Raymond JamesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2015Wells FargoDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015Northland SecuritiesDowngradeOutperform -> Market Perform$55.00 -> $63.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2015OppenheimerBoost Price TargetOutperform$49.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015BarclaysBoost Price TargetEqual Weight$40.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Credit SuisseSet Price TargetBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/5/2014SunTrustDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Bank of AmericaReiterated RatingNeutral$29.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Piper JaffrayDowngradeOverweight -> Neutral$40.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/20/2014WallachBeth CapitalLower Price TargetHold$38.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Thoratec (NASDAQ:THOR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
11/3/2015        
8/4/2015Q215$0.28$0.37$115.48 million$128.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.26$0.38$111.10 million$121.31 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414$0.24$0.39$106.90 million$127.96 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314$0.22$0.18$106.30 million$105.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214$0.43$0.43$128.30 million$118.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114$0.39$0.41$122.56 million$125.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413$0.41$0.38$128.47 million$128.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313$0.40$0.49$121.25 million$126.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.43$0.52$121.51 million$130.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.46$0.41$122.53 million$117.73 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2013Q4 2012$0.38$0.38$119.09 million$128.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.39$0.41$111.80 million$117.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012$0.45$0.45ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012$0.41$0.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.33$0.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2011$0.35$0.44ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.33$0.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$0.30$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Thoratec (NASDAQ:THOR)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Thoratec (NASDAQ:THOR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Thoratec (NASDAQ:THOR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/26/2015Neil F DimickDirectorSell8,173$44.98$367,621.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Paul A LavioletteDirectorSell5,668$44.70$253,359.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2015Neil F DimickDirectorSell4,786$43.00$205,798.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014J Daniel ColeDirectorSell5,000$31.83$159,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Neil F DimickDirectorSell4,158$32.15$133,679.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Paul LavioletteDirectorSell6,023$31.23$188,098.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Gerhard BurbachCEOSell22,104$36.53$807,459.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Gerhard BurbachCEOSell20,000$34.71$694,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014Gerhard BurbachCEOSell9,400$38.10$358,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Gerhard BurbachCEOSell30,600$36.65$1,121,490.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2013Gerhard BurbachCEOSell40,000$38.15$1,526,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2013Gerhard BurbachCEOSell100,000$41.40$4,140,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Gerhard F BurbachCEOSell15,000$40.02$600,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/17/2013Gerhard F BurbachCEOSell9,600$39.00$374,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2013Gerhard BurbachCEOSell40,400$38.17$1,542,068.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/11/2013David Aaron LehmanSVPSell21,889$38.17$835,503.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Neil F DimickDirectorSell1,273$31.58$40,201.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Neil F DimickDirectorSell1,250$31.61$39,512.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Neil F DimickDirectorSell1,250$33.93$42,412.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Gerhard F BurbachCEOSell11,600$38.09$441,844.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/4/2012David Aaron LehmanSVPSell12,300$36.11$444,153.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Thoratec (NASDAQ:THOR)
DateHeadline
06/28/16 09:16 AMMedtronic in $1.1bn deal to buy HeartWare
06/27/16 06:39 PMMedical device maker Medtronic to buy HeartWare for $1.1B
06/21/16 06:16 PMCardiac Equipment Industry Sales, Supply and Consumption 2016 Analysis and Forecasts to 2020
06/19/16 08:49 AMCardiac Surgery Devices Market: Global Industry Analysis and Forecast 2016 - 2026
06/01/16 07:30 PMGermany Cardiovascular Devices Market Outlook to 2021 - New Market Research Report - Maquet Holding B.V. & Co. KG., Sorin S.p.A., Thoratec Corporation, Biosense Webster, Inc., HeartWare International, Inc., C. R. Bard, Inc., Terumo Corporation, Abbott Laboratories, Teleflex Incorporated, B. Braun Melsungen AG, Biotronik SE & Co. KG ...
05/28/16 02:44 AMNew Study: Asia-Pacific Cardiac Assist Devices Market Outlook to 2021 - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporated and Others. Reasons to Get this Report * Develop business strategies by identifying the key market segments poised for ...
05/25/16 10:39 AMCalifornia Life Sciences Association Elects Leaders from Merck, Organovo and St. Jude Medical to its Board of Directors - Murphy has more than 20 years of experience in biotechnology, including co-founding Organovo in 2007 and serving in ... He is currently leading the integration of Thoratec into St. Jude Medical, the largest acquisition in St. Jude Medical history.
05/25/16 10:39 AMNew Study: Italy Cardiac Assist Devices Market Outlook to 2021 - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporated and Others. Reasons to Get this Report * Develop business strategies by identifying the key market segments poised for ...
05/17/16 11:30 AMEU5's cardiac assist devices market share to 2021 made available by top research firm - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporated and Others. - Develop business strategies by identifying the key market segments poised for strong growth in the future.
05/16/16 08:25 PM2021 United States Cardiovascular Devices Market Analysis and Forecast - Boston Scientific Corporation, Thoratec Corporation, Terumo Corporation, Biosense Webster, Inc., Abbott Laboratories, Cordis Corporation, Maquet Holding B.V. & Co. KG., C. R. Bard, Inc., Sorin S.p.A., Biotronik SE & Co. KG, Cook Medical Incorporated and W.
05/14/16 01:50 AMAsia-Pacific Cardiac Assist Devices Market Share,Supply and Consumption 2016 to 2021 Market Research Report - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporated and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth ...
05/13/16 04:13 AMMechanical Circulatory Support in the New Era: An Overview - ASAIO J. 2013;59:41–5. Thoratec Corporation. HeartMate II Clinical Outcomes. http://www.thoratec.com/vad-trials-outcomes/clinical-outcomes/hm2-ce-phase1.aspx. Accessed November 2015 Timms D. A review of clinical ventricular assist devices. Med Eng Phys.
05/13/16 04:13 AMCardiac Assist Devices Market Dynamics, Forecast, Analysis and Supply Demand 2015-2025 - Cardiac Assist Devices Market: Key Players Some of the key market players in global cardiac assist devices market are Thoratec Corporation, MAQUET GmbH & Co., Teleflex Incorporated, Heart Ware International, Berlin Heart GmbH, ABIOMED and SynCardia Systems ...
05/12/16 05:16 AMBrazil Cardiac Assist Devices Market Outlook to 2021 Fundamental Concepts and Current Research - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporated and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth ...
05/10/16 09:19 PMChina Cardiac Assist Devices Market Outlook to 2021 Overview, Shares, Size and Forecast Report - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc. and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future.
05/10/16 09:19 PMCardiac Assist Devices Market in France Analysis for 2021 - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporated and Others. - Develop business strategies by identifying the key market segments poised for strong growth in the future.
05/09/16 09:41 PMSouth Korea Cardiac Assist Devices Market to 2021 – Analysis of Thoratec Corporation, Maquet Holding B.V. & Co. KG and Others - WiseGuyReports.com adds “South Korea Cardiac Assist Devices Market Outlook to 2021” new report to its research database. The report Spread across 46 pages with tables and figures. The new report, South Korea Cardiac Assist Devices Market Outlook to ...
05/07/16 07:09 PMRecent research: 2021 Germany cardiac assist devices market research outlook - Companies involved in this research Thoratec Corporation, HeartWare International, Inc., Maquet Holding B.V. & Co. KG., Berlin Heart GmbH, Teleflex Incorporated and SynCardia Systems, Inc. Market size for Cardiac Assist Devices market segments - Intra ...
05/06/16 05:10 AMAbbott Laboratories acquires St. Jude Medical in $25B deal - JPMorgan Chase & Co.'s price objective indicates a potential upside of 6.05% from the company's current price. It's annualized $5.9 billion in revenue includes full-year revenue from Thoratec, a maker of expensive advanced heart devices for heart failure ...
05/05/16 01:37 AMAbbott Boosts Cardio Device Business With $25 Billion St. Jude Buy - It's annualized $5.9 billion in revenue includes full-year revenue from Thoratec, a maker of expensive advanced heart ... an analyst with JPMorgan Chase & Co. in NY, in a note to investors. "Today is about St. Jude". The deal would move Abbott, based ...
05/05/16 01:37 AMNewly released market study: United Kingdom Cardiac Assist Devices Market Outlook to 2021 - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporatedand Others. Fast Market Research is a leading distributor of market research and business information. Representing the ...
05/02/16 02:00 AMAbbott agrees to buy St Jude Medical for US$25bil - St. Jude has devices, like left ventricular assist devices (LVADs) for heart failure (from the Thoratec acquisition), ICDs and pacemakers ... "ORCRP010217-topic.html" class="local_link" >JPMorgan Chase & Co in NY, said in a note to investors.
04/29/16 09:45 PMDeal Watch: A Pharmaceutical Frenzy for a Half-Dozen Firms - Abbott Laboratories Co. is bringing back the megadeal like its 2015 ... As for St. Jude, last year Gibson Dunn advised the company on its $3.4 billion buy of Thoratec, a company that makes devices designed to combat heart failure. Jason Zellers, a former ...
04/29/16 05:17 AMMoody's reviews St. Jude Medical's Baa2 rating for downgrade - St. Jude reported revenues of about $5.5 billion for fiscal 2015. The company purchased Thoratec Corporation for approximately $3.3 billion, net of cash acquired, in October 2015. For ratings issued on a program, series or category/class of debt ...
04/27/16 10:08 PMResearch details developments in the United States cardiac assist devices market for 2021 - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporatedand Others. - Develop business strategies by identifying the key market segments poised for strong growth in the future.
04/26/16 05:14 AM2021 United States Cardiac Assist Devices Market Analysis and Forecast - Thoratec Corporation HeartWare International, Inc. Maquet Holding B.V. & Co. KG. Teleflex Incorporated SynCardia Systems, Inc. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles ...
04/23/16 02:52 AMUnited States Cardiac Assist Devices Market Outlook Analysis to 2016 & Forecast to 2021 - Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporatedand Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in ...
04/21/16 10:06 AMThoratec Acquisition: The Impact on St. Jude’s Growth Potential -
04/19/16 08:42 AMHow Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock? -
04/06/16 10:17 AMNew Market Report: Thoratec Corporation (THOR) - Medical Equipment - Deals and Alliances Profile - (live-PR.com) - Thoratec Corporation (Thoratec) is a medical device company. It undertakes the research, development, manufacture and marketing of proprietary medical devices used for mechanical circulatory support for the treatment of heart failure (HF ...
04/01/16 09:33 PMFuture Trends in Artificial Vital Organs and Medical Bionics Market with Analysis by 2018 - The artificial vital organs and medical bionics market report concludes with the profiles of major players having presence in the market such as Abbott Diabetes Care, AbioMed, Baxter International, Fresenius Medical Care, Thoratec Corporation, Otto Bock ...
03/23/16 09:28 PMProcyrion Appoints New Board Member - From 2006 to 2014, Mr. Burbach served as president, chief executive officer, and director of Thoratec Corporation, a worldwide leader in mechanical circulatory support (MCS) technology for the treatment of advanced heart failure (HF). Mr. Burbach led the ...
03/15/16 09:29 AMArtificial Organ And Bionics Market Trends, Company Share To 2020: Grand View Research, Inc. - Key industry participants include Abiomed Inc., Asahi Kasei Kuraray Medical Co. Ltd., Thoratec Corporation, WorldHeart Corp., Gambro AB and others. Read detailed report or request for sample of this research report: http://www.grandviewresearch.com ...
03/11/16 09:19 PMGlobal Artificial Organs and Medical Bionics Market to Register a CAGR of 9.20% from 2012 to 2018 Due to Increasing Demand for Organ Transplantation - Some of the top players in the global artificial organs and medical bionics market are Abbott Diabetes Care, Fresenius Medical Care, AbioMed, Baxter International, Otto Bock Healthcare, Thoratec Corporation, WorldHeart Corporation, and SynCardia Systems ...
03/04/16 11:49 AMArtificial Organs Market: Segments, Dynamics, Size, Forecast , Supply & Demand Value Chain, Current Issues and Forecast to 2015 to 2021 - The major companies operating in this market are ABIOMED, Inc., Berlin Heart GmbH, Biomet, Inc., Asahi Kasei Medical Co., Ltd., Thoratec Corporation, Cochlear Ltd, and HeartWare, Inc. Some of the other companies having a significant presence in the ...
03/03/16 11:52 AMCodexis Adds Life Sciences Industry Veteran David V. Smith To Its Board Of Directors - He previously was Executive Vice President and Chief Financial Officer of Thoratec Corporation, a leader in developing therapies for advanced heart failure, where he led actions to improve financial controls, analytics and processes. Prior to that he held ...
03/02/16 11:42 AMDigiSight Technologies Expands Senior Management Team To Support Paxos™ Mobile Health Platform Launch And Future Development - Mr. Jones held prior product management positions at Thoratec Corporation and LifeScan, where he focused on the development of medical technologies for cardiology. About DigiSight Technologies, Inc. DigiSight Technologies, Inc., based in San Francisco ...
03/01/16 06:26 PMCardiac Assist Devices Market, 2015-2025 by Segmentation: Based on Product, Application and Region - Future Market Insights has announced the addition of the “Cardiac Assist Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering. This press release was orginally distributed by SBWire Valley Cottage, NY ...
02/29/16 06:21 PMCFO Moves: Noble Corporation, WEX, Zeltiq Aesthetics - Mr. Harris was most recently CFO at Thoratec Corporation from 2012 to 2015, when the company was acquired by St. Jude Medical Inc. Prior to Thoratec, he spent a decade at J.P.Morgan Chase & Co. in various roles. Mr. Harris’ compensation details were not ...
02/22/16 05:45 PMIntersect ENT Appoints David Lehman General Counsel - Mr. Lehman brings three decades of legal experience to Intersect ENT, most recently having served as general counsel and secretary for Thoratec Corporation (NASDAQ:THOR), a global leader in medical technology to address advanced-stage heart failure ...
01/20/16 03:59 PMGlobal Bio-Implant Market Report 2016 - Forecasts to 2021 - PLC - Zimmer holdings - Wright medical group incorporated - WL Gore & associates Inc - Tornier N.V. - Thoratec corporation - St. Jude medical Inc - Sorin S.P.A. - Intuitive surgicals
01/16/16 05:13 PMNew Activist Hedge Fund by Ex-J.P. Morgan Deal Makers Makes First Investment - A new activist hedge fund started by high-profile ex- J.P. Morgan Chase & Co. deal makers Douglas Braunstein and James ... following the path of its rival, Thoratec Corp., which agreed to a $3.4 billion sale to St. Jude Medical Inc. last summer.
01/13/16 11:59 AM[$$] St. Jude to Meet Profit View -
10/08/15 03:52 PMTHORATEC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
10/07/15 03:44 PMThoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec - [at noodls] - PLEASANTON, Calif., Oct. 7, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today ...
10/06/15 07:34 AMThoratec Highlights Clinical Events From The European Association For Cardio-Thoracic Surgery Conference - [at noodls] - PLEASANTON, Calif., Oct. 6, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, highlighted ...
10/01/15 05:06 AMTHORATEC CORP Files SEC form 8-K, Other Events -
09/30/15 05:05 PMVerisk Analytics Set to Join the S&P 500; Joy Global to Join S&P MidCap 400 - [PR Newswire] - NEW YORK, Sept. 30, 2015 /PRNewswire/ -- S&P 500 constituent Joy Global Inc. (NYSE: JOY) will replace Thoratec Corp. (NASDAQ: THOR) in the S&P MidCap 400, and Verisk Analytics Inc. (NASDAQ: VRSK) will ...
09/28/15 03:00 PMThoratec's HeartMate III CE Mark Trial Results Positive -
09/27/15 03:15 PMHeartMate 3™ CE Mark Trial Meets Primary Endpoint - [at noodls] - PLEASANTON, Calif., Sept. 27, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, today announced ...
About Thoratec

Thoratec logoThoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company's products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company's product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: THOR
  • CUSIP: 88517530
Key Metrics:
  • Previous Close: $63.50
  • 50 Day Moving Average: $63.03
  • 200 Day Moving Average: $51.62
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Quarter EPS Consensus Estimate: $1.37 EPS
Additional Links:
Thoratec (NASDAQ:THOR) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha